Your browser doesn't support javascript.
loading
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model.
Fraticelli, Laurie; Freyssenge, Julie; Promé-Combel, Emilie; Agnellet, Eléonore; Dargaud, Yesim; Chamouard, Valérie.
Afiliación
  • Fraticelli L; Laboratory P2S (Health Systemic Process), UR 4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Freyssenge J; Research on Healthcare Performance RESHAPE, INSERM U1290, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.
  • Promé-Combel E; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Agnellet E; Pharmaceutical Unit, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Dargaud Y; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Chamouard V; French Reference Center of Hemophilia and Rare Inherited Bleeding Disorder, Louis Pradel Hospital, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
JMIR Res Protoc ; 12: e43091, 2023 Mar 08.
Article en En | MEDLINE | ID: mdl-36884286

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: JMIR Res Protoc Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: JMIR Res Protoc Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Canadá